FDA warns Doc Ackerman Pet Products that its Epilepsy & Seizure Formula for dogs and cats is an unapproved new animal drug.
What happened
FDA reviewed the firm’s Facebook account in October and November 2024 and reviewed third-party webpages. FDA found the firm directs customers to Doc Ackerman's Epilepsy & Seizure Formula on Amazon and Only Natural Pet Store and offers the product for sale there. FDA also found claims on labeling and webpages that the product treats epilepsy and seizures in dogs and cats.
What FDA found
The product is a drug because its name, labeling, and promotional claims say it treats epilepsy and seizures in animals and affects the body.
FD&C Act section 201(g)(1) [21 U.S.C. 321(g)(1)]It is a new animal drug because it is not generally recognized by qualified experts as safe and effective for the labeled uses.
FD&C Act section 201(v) [21 U.S.C. 321(v)]It has no approved new animal drug application, conditional approval, or index listing, so FDA considers it unsafe and adulterated.
FD&C Act sections 512(a) and 501(a)(5) [21 U.S.C. 360b(a), 351(a)(5)]The firm introduces or delivers the product into interstate commerce, which the FD&C Act prohibits for this product.
FD&C Act section 301(a) [21 U.S.C. 331(a)]
What FDA wants
Within 15 working days of receipt, notify FDA’s Center for Veterinary Medicine in writing of the specific steps taken to address the violations, explain how recurrence will be prevented, and include related documentation. If corrective action cannot be completed in that time, state the reason and when it will be completed.
Who should pay attention
- pet owners who buy seizure remedies online
- retailers and online marketplaces selling pet remedies
- makers of herbal pet products with disease-treatment claims
This is a summary. Read the original letter on fda.gov.